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Abstract: Anaplastic large cell lymphoma (ALCL) is a mature T cell lymphoma with characteristic morphologic, im-
munophenotypic and cytogenetic features. Current WHO classification includes anaplastic lymphoma kinase (ALK)-
positive and ALK-negative variants. ALCL rarely presents with obstructive symptoms of the main airway. In addition 
to reporting a HIV-associated bronchial ALK-negative ALCL in a 44 year-old female, our literature review identified 
eight cases of bronchial ALCL with several interesting clinicopathological features, including: 1) a female predomi-
nance (67%); 2) two thirds of patients younger than 18 years old; 3) uniformly presented with respiratory symptoms 
and progressed to respiratory failure; 4) the tumor involving the main airways; 5) often with localized disease at the 
initial presentation. This unusual presentation of ALCL may pose as a diagnostic pitfall and delay the treatment. 
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Introduction
Anaplastic large cell lymphoma (ALCL) is a 
CD30+ mature T cell lymphoma with character-
istic morphology and immunophenotype. 
According to the current WHO classification, 
there are two variants: ALCL, ALK (anaplastic 
lymphoma kinase)-positive (ALCL, ALK+) and 
ALCL, ALK-negative (ALCL, ALK-), which have 
many similar features. Both variants show mod-
est male predominance and involve both lymph 
nodes and extranodal sites. ALCL, ALK+ is more 
often seen in the first three decades of life and 
by definition, carries a translocation of the ALK 
gene and over-expresses the ALK protein [1]. In 
comparison, ALCL, ALK- is usually in middle-
aged group with a worse prognosis [2]. 
Among extranodal presentations, rare ALCL 
cases have been reported to present with 
respiratory complaints and later a bronchial 
mass was found. Up to date, there were 8 such 
cases reported in the English literature [3-10]. 
All of the eight reports are single case report, 
and so far no review is available about clinical 
and pathological features of this rare presenta-
tion. In addition to reporting one case of bron-
chial ALCL in an HIV patient, our literature 
review identified some interesting clinical fea-
tures of bronchial ALCL.
Case report
The patient was a 44-year-old female with a his-
tory of HIV infection for 11 years. She present-
ed with shortness of breath, fevers, night 
sweats, and quickly progressed to acute respi-
ratory failure. Imaging showed narrowing of the 
proximal left lower lobe pulmonary artery and 
surrounding metabolically active left hilar 
lymphadenopathy. No additional sites of 
involvement were identified. Flexible bronchos-
copy identified a protruding endobronchial 
lesion at the left main bronchus. The lesions 
were biopsied for histologic examination. 
The biopsy showed tiny fragments of soft tissue 
with a proliferation of medium-to-large sized 
neoplastic cells, which are dispersed in a back-
ground of mixed reactive inflammatory cells. 
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The neoplastic cells had moderate amount of 
granular, eosinophilic cytoplasm, coarse chro-
matin, single to several nucleoli. Occasional 
kidney-bean shaped nuclei were seen, resem-
bling “hallmark cells” (Figure 1A, 1B). 
Immunohistochemistry revealed the neoplastic 
cells were positive for CD45, supporting a 
hematolymphoid origin. The cells were negative 
for CD3 (Figure 1C), but positive for several 
other T cell makers, including CD2, CD4 (data 
not shown), and CD5 (Figure 1D). The expres-
sion of CD7 was down-regulated (data not 
shown). Pan B cell markers were all negative. 
CD30 was strongly positive (Figure 1E). CD15 
only highlighted smaller-sized neutrophils (data 
not shown). ALK-1 immunostain was negative 
(Figure 1F). The overall findings were consis-
Figure 1. Anaplastic large cell lymphoma, ALK negative from left main bronchus. (A, B): The neoplastic cells are large 
in size, with moderate amount of eosinophilic cytoplasm, vesicular chromatin. Occasional “hallmark cells” are seen. 
The neoplastic cells are negative for CD3 (C), and positive for CD5 (D), CD30 (E). ALK-1 is negative (F).
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tent with a mature T cell lymphoma, most favor 
ALCL, ALK-.
The patient was treated with cyclophospha-
mide, doxorubicin, etoposide, vincristine and 
prednisone. She had been in remission up to 6 
months.
Discussion
It is extremely rare for ALCL to initially present 
with respiratory symptoms. Our review of 
English literature had identified eight cases 
[3-10], summarized in Table 1. Including the 
current case, there were 9 patients in total with 
3 male and 6 female (male to female ratio of 
1:2). The median age was 16 years (ranging 
from 7 to 44 years). Sixty-seven percent of the 
group was < 18 years old. The sites of main air-
way involvement include the left main bronchus 
in 6 cases (67%), the right main bronchus in 2 
cases (22%), and the trachea in 1 case (11%). 
All of the cases initially presented with respira-
tory symptoms and later progressed to respira-
tory failure. Seven cases had imaging studies 
and/or bone marrow biopsies to evaluate sys-
temic involvement, six cases (86%) of which 
showed no evidence of systemic disease. Six of 
eight cases (75%) reported ALK immunoreac-
tivity in the neoplastic cells. Two cases, includ-
ing the current one, had a prior history of HIV 
infection [5]. HIV test was negative in Case #4 
and the rest six cases did not report HIV status. 
The median duration of follow-up was 6 months 
(ranging from 5 to 108 months), during which 
six patients were in remission. On the other 
hand, Case #3 and #5 did not achieve initial 
remission and the patients passed away 5 and 
6 months after the diagnosis, respectively.
It is known that HIV infection is associated with 
increased risks of developing various malignan-
cies, including hematopoietic malignancies, 
among which a 15-fold risk of developing T-cell 
lymphoma has been reported [11]. ALCL is the 
second most common subtype of T-cell lympho-
mas in HIV patients [12]. Interestingly, one 
study showed the majority of the HIV-associated 
ALCL are ALK-negative variant [13]. Our case is 
the first reported HIV-associated ALCL, ALK- 
presented as a bronchial mass. 
In summary, the initial bronchial involvement of 
ALCL was associated with some interesting 
clinicopathologic features: 1) There is a female 
predominance, in contrast to male predomi-
nance in the general ALCL group; 2) Majority of 
the patients are less than 18 year-old; 3) The 
patients uniformly present with obstructive 
symptoms of respiratory tract and usually 
develop respiratory failure; 4) The primary neo-
plasm is in the bronchus or the trachea; 5) At 
the initial presentation, majority of the cases 
have only localized disease.
Even though limited by the number of cases 
available, our analysis suggested that this 
group of ALCL have unusual presentation and 
could pose as a diagnostic challenge. It is espe-
cially true in the youth, for whom non-malignant 
respiratory diseases are much more common. 
On the other hand, a timely diagnosis is critical 
to avoid disease progression and complica-
tions from respiratory failure, which had been 
reported in all the nine cases. The author hopes 
this review could draw attention to and help our 
understanding of this rare presentation of 
ALCL. In addition, bronchial ALCL need be con-
Table 1. The summary of clinicopathologic features of nine cases of bronchial / tracheal ALCL






Status ALK IHC Follow-Up Ref.
1 28/M LMB Yes No N/A N/A DFS 5 mo Kim et al, 1998
2 17/F LMB Yes N/A N/A Pos N/A Bhalla et al, 2003
3 23/M LMB Yes Yes* Pos Pos Expired in 5 mo Barthwal et al, 2005
4 9/F LMB Yes No Neg Pos DFS 48 mo Guerra et al, 2006
5 7/F LMB Yes N/A N/A Neg Expired in 6 mo Kuperman et al, 2006
6 16/F Trachea Yes No N/A Pos DFS 25 mo Khodadad et al, 2011
7 13/F RMB Yes No N/A Pos DFS 108 mo Pavlov et al, 2012
8 16/M RMB Yes No N/A Pos DFS 6 mo Zhang et al, 2012
9 44/F LMB Yes No Pos Neg DFS 6 mo Current 
ALK: Anaplastic lymphoma kinase; DFS: disease free survival; F: female; IHC: immunohistochemistry; LMB: left main bronchus; 
M: male; mo: months; N/A: not available; Ref: reference; RMB: right main bronchus. *The disease involved supraclavicular and 
axillary lymph nodes, right thigh and bone marrow.
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sidered in the differential diagnosis if airway 
obstruction is suspected, especially in a young 
patient.
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